Accolade Inc (NAS:ACCD)
$ 6.68 -0.2 (-2.91%) Market Cap: 523.42 Mil Enterprise Value: 528.04 Mil PE Ratio: 0 PB Ratio: 1.17 GF Score: 75/100

Accolade Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 12:45PM GMT
Release Date Price: $47.78 (+1.31%)
Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP

Good morning, everyone, and thanks for attending the Morgan Stanley Global Healthcare Conference. My name is Craig Hettenbach. I'm a new member of the health care services team. Very pleased to have Accolade CEO, Rajeev Singh; and CFO, Steve Barnes, with us here today. The company is a leading provider of tech-enabled services to help individuals navigate the health care ecosystem.

Before we get started, just for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And for investors on the webcast, you can submit questions.

Questions & Answers

Craig Matthew Hettenbach
Morgan Stanley, Research Division - VP

So with that, Rajeev, if we can just start on 2 new important elements to the story, the acquisitions of PlushCare and 2nd.MD. Really how they fit into the strategy, the capabilities that they bring and how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot